Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study

By Schmid Peter   Schweigert Marcus   Beinert Thomas   Flath Bernd   Sezer Orhan   Possinger Kurt  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite

A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors

By Hilgers Werner   Faivre Sandrine   Chieze Stéphanie   Alexandre Jérôme   Lokiec François   Goldwasser François   Raymond Eric   Kahatt Carmen   Taamma Abdelkrim   Weems Garry   MacDonald John   Misset Jean-Louis   Cvitkovic Esteban  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 311-319

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of trabectedin and carboplatin in patients with advanced solid tumors

By Vidal Laura  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 616-628

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

By Hubbard Joleen   Erlichman Charles   Toft David   Qin Rui   Stensgard Bridget   Felten Sara   Ten Eyck Cynthia   Batzel Gretchen   Ivy S.   Haluska Paul  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 473-480

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

By Nock Charles   Brell Joanna   Bokar Joseph   Cooney Matthew   Cooper Brenda   Gibbons Joseph   Krishnamurthi Smitha   Manda Sudhir   Savvides Panayiotis   Remick Scot   Ivy Percy   Dowlati Afshin  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 126-130

Springer Publishing Company

Access to resources Recommend Favorite